Recombinant human Kallikrein 13/KLK13 protein from NKMAX Co. Ltd.

Search, find, compare suppliers for Recombinant human Kallikrein 13/KLK13 protein products.

Edit 
Product NameRecombinant human Kallikrein 13/KLK13 protein
DescriptionDomain: 17-277aa. Recombinant human KLK13 protein, fused to His-tag at N-terminus, was expressed in E. coli. MW: 31.3 kDa (284aa). Purity > 90% by SDS-PAGE. Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. KLK13 is one of the fifteen kallikrein subfamily members located in a cluster on chromosome 19. Expression of this gene is regulated by steroid hormones and may be useful as a marker for breast cancer. An additional transcript variant has been identified, but its full length sequence has not been determined
Size10ug, 50ug
Concentration0.25mg/ml (determined by Bradford assay)
ApplicationsSDS-PAGE, Denatured
Other NamesKallikrein related peptidase 13, Kallikrein-13 Kallikrein-like protein 4, KLK-L4
Gene, Accession, CAS #NCBI: NP_056411, UniProt: Q9UKR3
Catalog #ATGP2949
Price$240, $720
Order / More InfoRecombinant human Kallikrein 13/KLK13 protein from NKMAX Co. Ltd.
Product Specific Referencesn/a
NKMAX Co. Ltd.
NKMAX Co. Ltd.
NKMAX Co. Ltd.
6F, SNUH Health Care Innovation Park
172 Dolma-ro, Bundang-gu
Seongnam-si, Gyeonggi-do 13605 REPUBLIC OF KOREA
P: +82-31-8017-8114
F: +82-31-8017-8124

salesbio@nkmax.com

http://www.nkmaxbio.com

Profile of NKMAX Co. Ltd.

© 1980 - 2024 Linscott's Directory, Linscott's USA. All rights reserved.